Back to BlackRock, Inc. BlackRock, Inc.

LGNDLGND
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in LIGAND PHARMACEUTICALS

BlackRock, Inc. holds 3.1M shares of LGND (LIGAND PHARMACEUTICALS), worth $980.2M as of 2026-Q2. The position was increased (+4.7% shares). LGND represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$980.2M

Current Shares

3.1M

Total Value Change

+$664.5M

Total Shares Change

+154,912

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.1M
+4.7%
$980.2M0.0%$316.09
33
2026-Q1
Increased
3M
+0.7%
$591.3M0.0%$204.24
32
2025-Q4
Increased
2.9M
+1.9%
$555.9M0.0%$190.20
32
2025-Q3
Decreased
2.9M
-1.0%
$511M0.0%$173.13
0
2025-Q2
Decreased
2.9M
-0.2%
$331.2M0.0%$114.15
0
2025-Q1
Decreased
2.9M
-0.9%
$307M0.0%$107.62
0
2024-Q4
New
2.9M
-
$315.7M0.0%$105.76
43

Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, Invesco Ltd., VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used